NCT00136942 - A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol | Biotech Hunter

Enrollment

370

Participants

Timeline

Start Date

April 30, 2005

Conditions

Hyperlipidemia

Interventions

DRUG

Atorvastatin

Trial Locations (20)

Pfizer Investigational Site, Binningen

Pfizer Investigational Site, Liestal

Pfizer Investigational Site, Basel

Pfizer Investigational Site, Langenthal

Pfizer Investigational Site, Thun

Pfizer Investigational Site, Düdingen

Pfizer Investigational Site, Geneva

Pfizer Investigational Site, Onex

Pfizer Investigational Site, Pfaeffikon

Pfizer Investigational Site, Siebnen

Pfizer Investigational Site, Écublens

Pfizer Investigational Site, Lausanne

Pfizer Investigational Site, Prilly

Pfizer Investigational Site, Unterägeri

Pfizer Investigational Site, Zug

Pfizer Investigational Site, Zurich

Pfizer Investigational Site, Lugano

Pfizer Investigational Site, Malvaglia

Pfizer Investigational Site, Melide

Pfizer Investigational Site, Vezia

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY